Nextech3D.AI will issue 7.42 million shares to CEO Evan Gappelberg to settle $742,088 in unpaid salary. This share issuance reduces company liabilities and preserves cash for growth initiatives like sales expansion and product development. The CEO's choice to accept shares aligns his interests with shareholders, and he remains a major investor in the company. Nextech3D.AI focuses on AI-driven event technology and immersive digital experiences, with recent stock gains reflecting investor optimism.
Nextech3D.ai CEO's share issuance news comes alongside a strong Technology sector performance on Pluang. For readers following this sector, here is Pluang's market snapshot as of Sep 17, 2026 23:02 WIB: Out of 150 priced US tech stocks, 119 rose and 30 fell today. Notably, SMCI gained 9.12% to USD 40.21 with a typical hold time of 18 days and a buy order activity of 57%, while RGTI increased 8.59% to USD 16.06 with a 30-day hold and 87% buy orders. QBTS also rose 8.48% to USD 17.65 but saw 97% sell orders despite a 29-day hold time.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
